Innovative R&D Products

Teva's proprietary research and development pipeline is currently focused primarily on three niche specialty areas: neurological disorders, autoimmune diseases and oncology. Currently there are several innovative products in advanced development stages for the treatment of Multiple sclerosis, Crohn's disease , ALS and more. One element of Teva's approach to innovative product development is to leverage the advantages arising from Teva's status as the world's leading generic company, such as its relationships with health insurers and the trade.

In building its pipeline, Teva focuses on products with meaningful differentiation from existing products in terms of clinical attributes and expected economic value and benefit to patients and health insurers. In addition, different new technologies are incorporated early in the development process to reduce the risk at more advanced stages of R&D (e.g., biomarkers)

Your Partner in Speciality Product Development

At Teva, we built our successful reputation on the development, production and marketing of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients.

Our emphasis is on bringing specialty products to market